Worldwide Proteomics Industry to 2025 – Availability of Government and Private Funding Presents Opportunities – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Proteomics market (2020-2025) by Instrumentation Technology, Reagents, Services & Software, Application, Geography, Competitive Analysis and the Impact of Covid-19 with Ansoff Analysis” report has been added to ResearchAndMarkets.com’s offering.
The Global Proteomics Market is estimated to be USD 20.3 Bn in 2020 and is expected to reach USD 35.6 Bn by 2025, growing at a CAGR of 12%.
The transformation of the biopharmaceutical industry’s focus from genomics to system biology has led to an increase in the demand for proteomics. Also, certain drug manufacturers have started with their proteomic divisions boosting the growth of this market. The market is highly characterized by R&D investments and an increasing number of collaborations between enterprises.
Factors such as increasing demand for personalized medicine with a need to curb down the costs on healthcare by promoting effective drugs and the rise in the R&D for the former have promoted the growth of the proteomics market.
However, the constraining factor for market growth is strict regulatory norms and the instruments’ high cost. Lack of skilled professionals in the proteomics industry impedes the growth of the market. The opportunities associated with biomarker identification and developments in mass spectrometry-based proteomics are expected to provide lucrative growth opportunities to the market.
Market Dynamics
Drivers
- Increase in Popularity of Personalized Medicines
- An Upsurge in R&D Expenditure
- Technological Advancements Associated with Proteomics Components
Restraints
- High Costs Associated with Proteomics Components
- The dearth of Skilled Professionals
- Huge Disconnect Between Biomarker Discovery and Biomarker Approval By Regulatory Authorities
Opportunities
- Lucrative Opportunities Associated with Biomarker Identification
- Developments in Mass Spectrometry-Based Proteomics
- Availability of Government and Private Funding
- Technological Advancements
Challenges
- Regulatory Barriers
Trends
- Development in Mass Spectrometry-Based Proteomics
Why buy this report?
- The report offers a comprehensive evaluation of the Global Proteomics Market.
- The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes in-depth market analysis using Porter’s 5 force model and the Ansoff Matrix. The impact of Covid-19 on the market is also featured in the report.
- The report also contains a competitive analysis using Positioning Quadrants, a Proprietary competitive positioning tool.
Report Highlights:
- A complete analysis of the market including parent industry
- Important market dynamics and trends
- Market segmentation
- Historical, current, and projected size of the market based on value and volume
- Market shares and strategies of key players
- Recommendations to companies for strengthening their foothold in the market
Companies Mentioned
- Agilent Technologies, Inc.
- Danaher Corporation (Beckman Coulter, Inc.)
- Li-Cor Inc.
- PerkinElmer Inc.
- Thermo Fisher Scientific, Inc.
- Horiba Ltd.
- Bio-Rad Laboratories, Inc.
- Bruker Corporation (Beckman Coulter, Inc.)
- Ge Healthcare (General Electric)
- Waters Corporation (Beckman Coulter, Inc.)
- Roche Diagnostics
For more information about this report visit https://www.researchandmarkets.com/r/trzz24
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
